Patients say they want Alzheimer’s blood tests. Doctors aren’t sure they help. - BERITAJA

Albert Michael By: Albert Michael - Monday, 27 April 2026 16:00:00 • 7 min read
Patients say they want Alzheimer’s blood tests. Doctors aren’t sure they help. - BERITAJA

Patients say they want Alzheimer’s blood tests. Doctors aren’t sure they help. - BERITAJA is one of the most discussed topics today. In this article, you will find a clear explanation, key facts, and the latest updates related to this topic, presented in a concise and easy-to-understand way. Read more news on Beritaja.

The thought is straightforward: Take a humor test now, moreover without symptoms, and study if you could immoderate time create Alzheimer’s disease.

Whether you should get this trial is simply a much analyzable matter.

Most Alzheimer’s humor tests activity by measuring levels of amyloid aliases tau, proteins that build up successful the encephalon and are thought to play cardinal roles successful the disease. Both could statesman gathering successful the encephalon decades earlier immoderate symptoms appear.

But it’s still an ongoing statement really good the tests could foretell who will spell connected to create Alzheimer’s disease, doctors say. Some group who trial affirmative ne'er do, fueling suspicion about really reliable the results are successful the first place.

Even if the tests could accurately foretell risk, they raise a bigger question: what should patients do pinch the information? There is nary cure for Alzheimer’s disease, which affects about 7 cardinal group successful the U.S., according to the Mayo Clinic. The two narcotics approved by the Food and Drug Administration — Leqembi and Kisunla — purpose to slow, not cure, the disease. There’s mixed grounds for really good they work, and they travel pinch perchance superior broadside effects, including encephalon swelling and bleeding. Diet and workout may thief trim the risk of Alzheimer’s, but their effects are limited.

“The full thought of doing a trial to supply an early test of immoderate illness is that if we enactment early, we get amended results,” said Dr. Alberto Espay, a neurologist astatine the University of Cincinnati College of Medicine. “But location is zero grounds to show that group who are astatine the earliest stages [of Alzheimer’s disease] would use from thing we have.”

That hostility is reflected successful a study published earlier this period successful the diary Alzheimer’s & Dementia, which recovered that 85% of patients said they would return a humor trial to measure their Alzheimer’s consequence if their expert recommended it.

The study included responses from about 600 adults pinch an mean property of 62 astatine superior attraction clinics successful the Chicago area. About half reported having a family history of Alzheimer’s disease, though nary had been diagnosed. Most had ne'er heard of the tests earlier taking the survey.

The survey’s lead author, Andrea Russell, said the findings bespeak the worry she sees successful her older patients.

“A batch of group look to want to understand what’s happening to them,” said Russell, a objective and superior attraction scientist astatine Northwestern University Feinberg School of Medicine. The study besides recovered that about 3 successful 4 respondents said they would expect to consciousness distressed aft a affirmative result, moreover arsenic about said they would apt return steps to amended their encephalon health.

As a psychologist, Russell does not bid the tests for her patients. She said she has questions about the tests’ validity.

“There’s still a batch to beryllium ironed out. They’re still not fresh for premier time,” Russell said. “There is decidedly skepticism.”

The FDA has cleared 2 humor tests for Alzheimer’s, some successful the past year, for group 55 and older. They’re approved for group who are already showing symptoms of the disease, not for those without symptoms. The tests don’t diagnose Alzheimer’s connected their ain and are utilized alongside different tests, for illustration a PET scan. The FDA noted in 1 of its approvals that the main consequence of the tests is inaccurate results — including mendacious positives and mendacious negatives — which “could lead to an inappropriate test of, and unnecessary curen for, Alzheimer’s disease.”

Despite the existent limitations, location are astatine slightest 25 commercially disposable humor tests worldwide, and location are much successful development, according to the Alzheimer’s Association, a proponent of testing.

The support of humor tests isn’t only important for earlier diagnosis, but for ensuring that patients person easy entree to a diagnosis, according to Rebecca Edelmayer, the Alzheimer’s Association vice president of technological engagement. The tests, she said, are elemental to administer, comparatively inexpensive and much convenient than PET scans aliases MRI.

“There is beardown nationalist sentiment successful support of early Alzheimer’s test and treatment,” Edelmeyer said successful an emailed statement. “People want to cognize if they person Alzheimer’s aliases different illness that causes dementia, and they want to cognize earlier it impacts their regular life.”

Dr. Ronald Petersen, a neurologist astatine the Mayo Clinic successful Rochester, Minnesota, said the tests person improved “dramatically” successful caller years, though much activity is needed.

Petersen said the humor tests are mostly utilized successful 3 ways.

The first is prediction, estimating the likelihood that personification has amyloid successful the brain, which is past typically confirmed by a PET scan. That’s really the tests person been utilized successful objective trials, he said, arsenic a screening instrumentality to place which patients should spell connected to much costly imaging.

The 2nd is search treatment. In theory, doctors could usage humor tests complete clip to spot whether amyloid levels aliases different changes aft a diligent starts connected an Alzheimer’s drug.

The 3rd is diagnosis: whether a humor trial unsocial could corroborate Alzheimer’s illness by detecting amyloid aliases different markers of the illness successful the brain.

“I deliberation the assemblage is still retired connected that,” Petersen said. “Some group will return that and will say, ‘OK, bully capable for me.’ But I deliberation there’s been capable inconsistencies, discordances, mismatches betwixt humor tests, spinal fluid and PET scans, successful some directions, to make about group successful the section still skeptical about utilizing a humor trial alone.”

A 2024 study found humor tests correctly identified whether patients pinch representation problems had Alzheimer’s about 90% of the time, though experts noted it was conducted successful Sweden and would request to beryllium confirmed pinch studies successful the U.S., wherever the organization is much diverse. Last December, the Mayo Clinic presented information connected 1 of the FDA-approved Alzheimer’s humor tests — from Fujirebio — uncovering it whitethorn beryllium overly delicate and much apt to emblem patients arsenic affirmative than different methods.

Espay, of the University of Cincinnati, said different important information is that amyloid and different biomarker, tau, are besides coming successful the brains of immoderate older adults who whitethorn ne'er spell connected to create the disease.

It whitethorn not beryllium “telling you person a disease,” he said. “Pathology is what we are each processing arsenic we age, but very fewer of america will dice pinch the illness we’ve attributed the pathology to cause.”

Petersen said he’s hopeful that the tests will 1 time germinate and could 1 time beryllium utilized arsenic a lone instrumentality for diagnosis, though the section isn’t location yet.

Russell said patients desperately want to cognize whether the symptoms they’re experiencing are a normal portion of aging aliases thing more.

“It could make a meaningful quality and thief group consciousness for illustration they person dream and control,” Russell said.

This article discusses Patients say they want Alzheimer’s blood tests. Doctors aren’t sure they help. - BERITAJA in detail, including key facts, recent developments, and important insights that readers are actively searching for online.